Researchers develop first biohybrid artificial retina with silk fibroin and retinal cells
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.
The biohybrid retina is a cell therapy for the reconstruction of the damaged retina by implanting healthy cells in the patient s eye.
Fivos Panetsos, Director of the Neuro-computation and Neuro-robotics Group of the UCM and Member of the Institute of Health Research of the Hospital Clínico San Carlos de Madrid (IdISSC)
E-Mail The biohybrid retina is a cell therapy for the reconstruction of the damaged retina by implanting healthy cells in the patient s eye, says Fivos Panetsos, director of the Neuro-computation and Neuro-robotics Group of the UCM and member of the Institute of Health Research of the Hospital Clínico San Carlos de Madrid (IdISSC).
The cells of the artificial retina adhere to very thin silk fibroin biofilms - a biomaterial 100% biocompatible with human tissue - and covered by a gel which protects them during eye surgery and allows them to survive during the time they need to get integrated with thesurrounding tissue after transplantation.
Development of the first biohybrid artificial retina built with silk fibroin and retinal cells medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.